Abstract

This article provides a status report on the global burden of common cancers in male worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality. Based on the results of cancer records in 2018, 9,456,418 cases of malignancy were recorded in males, with lung cancer (1,368,524 cases, 14.5), prostate cancer (1,276,106 cases, 13.5), colorectal cancer (1,026,215 cases, 10.9 ), stomach cancer (683,754 cases, 7.2), and liver cancer (596,574 cases, 6.3) were the five most common cancers in men worldwide. The total number of deaths due to cancer in humans in 2018 is 5,385,640. The five causes of death due to cancer in men worldwide are lung cancer (1,184,947 cases, 22), liver (548,375 cases, 2.10), stomach cancer (513,555 cases, 9.5), colorectal cancer (484,224 cases, 9), and prostate cancer (358,989 cases, 7.7). Our results showed that there was a positive correlation between the incidence of lung cancer (R = 0.629, P < 0.0001), prostate cancer (R = 0.534, P < 0.0001), colorectal cancer (R = 0.745, P < 0.0001), and stomach cancer (R = 0.268, P < 0.001) with human development index (HDI) index, while there was no significant relationship between liver cancer and the HDI (R = 0.079, P > 0.05). The results also showed that there was a positive and significant correlation between mortality from lung cancer (R = 0.632, P < 0.0001) and colorectal cancer (R = 0.627, P < 0.0001) with HDI, whereas this correlation was negative for prostate cancer (R = -0.187, P < 0.01).